Benznidazol and Triazol Research Group for nanomedicine and Innovation on Chagas disease. (BERENICE)
- Researcher(s):
- Israel Medina (José Luis Pedraz va como IP dentro del grupo NanoBioCel del CIBER BBN)
- Period:
- from 2012 to 2017
- Financing entity:
- COMUNIDAD EUROPEA (FP7, PROGRAMA HEALTH). Proposal No 305937-1 FP7 Health 2012
- Total amount:
- 288.635 €